Boston CE marks Blazer RF catheter
This article was originally published in Clinica
Boston Scientific has CE marked its Blazer open-irrigated catheter for sale in Europe. The radiofrequency ablation (RFA) catheter is designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The Blazer catheter uses both internal cooling and external washing of the tip electrode, which is designed to reduce coagulum at the proximal edges of the tip. It will be launched this quarter in selected countries. The device is not yet approved in the US. Around 4.5 million Europeans have atrial fibrillation, the Natick, Massachusetts firm said.